Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese HSK 1 – For Medical Students & Physicians A complete 20-lesson, 300-page Chinese HSK 1 course with a companion app in 21 languages — free forever. Arabic, Bengali, Dutch, English, Farsi, French, German, Hindi, Indonesian, Italian, Japanese, Korean, Portuguese, Russian, Spanish, Tagalog, Thai, Turkish, Ukrainian, Urdu, Vietnamese. By Bernd Sebastian Kamps and Andrea Melis

Hypertension

Free Subscription Articles published in N Engl J Med Retrieve available abstracts of 57 articles: HTML format

Single Articles

April 2026
1. ANDERSON CS, Chow CK, de Silva HA, Senanayake B, et al
   Three Low-Dose Antihypertensive Agents in a Single Pill after Intracerebral Hemorrhage.
   N Engl J Med. 2026;394:1571-1582.
   PubMed     Abstract available
   
   
   
2. 
   Home-Based Care for Hypertension in Rural South Africa.
   N Engl J Med. 2026;394:1560.
   PubMed    
   
   
   
3. KHAN SS, Huffman MD
   Systems-Based Success for Hypertension.
   N Engl J Med. 2026;394:1445-1446.
   PubMed    
   
   
   
4. MILLS KT, Krousel-Wood M, Peacock EM, Chen J, et al
   Multifaceted Strategies for Hypertension Control in Low-Income Patients.
   N Engl J Med. 2026;394:1376-1387.
   PubMed     Abstract available
   
   
   March 2026
5. KOTANIDIS CP, Whelton PK, Wright CB
   Blood-Pressure Targets in Hypertension Management.
   N Engl J Med. 2026;394:1026-1029.
   PubMed    
   
   
   February 2026
6. BENETOS A, Gautier S, Rossignol P
   Reduction of Antihypertensive Treatment in Nursing Home Residents. Reply.
   N Engl J Med. 2026;394:932-933.
   PubMed    
   
   
   
7. FUJI S
   Reduction of Antihypertensive Treatment in Nursing Home Residents.
   N Engl J Med. 2026;394:932.
   PubMed    
   
   
   
8. ZHANG L, Yang L
   Reduction of Antihypertensive Treatment in Nursing Home Residents.
   N Engl J Med. 2026;394:931-932.
   PubMed    
   
   
   
9. HUART J, Jouret F
   Reduction of Antihypertensive Treatment in Nursing Home Residents.
   N Engl J Med. 2026;394:931.
   PubMed    
   
   
   
10. LU Y, Li L
    Reduction of Antihypertensive Treatment in Nursing Home Residents.
    N Engl J Med. 2026;394:930-931.
    PubMed    
    
    
    
11. STRANDBERG TE
    Reduction of Antihypertensive Treatment in Nursing Home Residents.
    N Engl J Med. 2026;394:930.
    PubMed    
    
    
    
12. FADAKAR PK, Pourvaziri A, Feldman AS, Pier DB, et al
    Case 5-2026: An 18-Year-Old Woman with Headache and Hypertension.
    N Engl J Med. 2026;394:700-709.
    PubMed    
    
    
    January 2026
13. KISHORE SP, Kocher R
    The Hypertension Control Paradox - Why Is America Stuck?
    N Engl J Med. 2026;394:417-420.
    PubMed    
    
    
    
14. HORTON JC
    Idiopathic Intracranial Hypertension. Reply.
    N Engl J Med. 2026;394:414-415.
    PubMed    
    
    
    
15. WANG Y, Liang Z, Weng D
    Idiopathic Intracranial Hypertension.
    N Engl J Med. 2026;394:414.
    PubMed    
    
    
    
16. XIAO YJ, Sun H
    Idiopathic Intracranial Hypertension.
    N Engl J Med. 2026;394:414.
    PubMed    
    
    
    
17. DO LAGO V, Caldas J
    Idiopathic Intracranial Hypertension.
    N Engl J Med. 2026;394:414.
    PubMed    
    
    
    
18. FLACK JM, Dwyer JP, Williams B
    Efficacy and Safety of Baxdrostat in Uncontrolled and Resistant Hypertension. Reply.
    N Engl J Med. 2026;394:305-306.
    PubMed    
    
    
    
19. JHAVERI KD, Hirsch JS, Fishbane S
    Efficacy and Safety of Baxdrostat in Uncontrolled and Resistant Hypertension.
    N Engl J Med. 2026;394:305.
    PubMed    
    
    
    
20. ZHENG Z, Jiang X, Wu B
    Efficacy and Safety of Baxdrostat in Uncontrolled and Resistant Hypertension.
    N Engl J Med. 2026;394:304.
    PubMed    
    
    
    
21. HIGASHI Y
    Efficacy and Safety of Baxdrostat in Uncontrolled and Resistant Hypertension.
    N Engl J Med. 2026;394:304.
    PubMed    
    
    
    
22. PEDREIRA-BOUZAS J, Pousada-Fonseca A
    Efficacy and Safety of Baxdrostat in Uncontrolled and Resistant Hypertension.
    N Engl J Med. 2026;394:303-304.
    PubMed    
    
    
    November 2025
23. GOREY S, Rothberg M, Chang TI
    To Treat or Not to Treat? Watchful Waiting or Oral Antihypertensives for Asymptomatic Inpatient Hypertension.
    N Engl J Med. 2025;393:2051-2053.
    PubMed    
    
    
    
24. PLACIDO R, Baptista B
    Ortner's Syndrome in Pulmonary Hypertension.
    N Engl J Med. 2025;393:e35.
    PubMed    
    
    
    
25. JIMENEZ C, Andreassen M, Durand A, Moog S, et al
    Belzutifan for Advanced Pheochromocytoma or Paraganglioma.
    N Engl J Med. 2025;393:2012-2022.
    PubMed     Abstract available
    
    
    October 2025
26. HORTON JC
    Idiopathic Intracranial Hypertension.
    N Engl J Med. 2025;393:1409-1419.
    PubMed    
    
    
    September 2025
27. MCLAUGHLIN VV, Hoeper MM, Badesch DB, Ghofrani HA, et al
    Sotatercept for Pulmonary Arterial Hypertension within the First Year after Diagnosis.
    N Engl J Med. 2025 Sep 30. doi: 10.1056/NEJMoa2508170.
    PubMed     Abstract available
    
    
    
28. SIEDNER MJ, Magula N, Mazibuko L, Sithole N, et al
    Home-Based Care for Hypertension in Rural South Africa.
    N Engl J Med. 2025 Sep 1. doi: 10.1056/NEJMoa2509958.
    PubMed     Abstract available
    
    
    August 2025
29. FLACK JM, Azizi M, Brown JM, Dwyer JP, et al
    Efficacy and Safety of Baxdrostat in Uncontrolled and Resistant Hypertension.
    N Engl J Med. 2025 Aug 30. doi: 10.1056/NEJMoa2507109.
    PubMed     Abstract available
    
    
    
30. GUZIK TJ, Tomaszewski M
    Aldosterone Synthase Inhibition for Hypertension.
    N Engl J Med. 2025 Aug 30. doi: 10.1056/NEJMe2511533.
    PubMed    
    
    
    
31. BENETOS A, Gautier S, Freminet A, Metz A, et al
    Reduction of Antihypertensive Treatment in Nursing Home Residents.
    N Engl J Med. 2025 Aug 29. doi: 10.1056/NEJMoa2508157.
    PubMed     Abstract available
    
    
    
32. LAFFIN LJ, Rodman D, Nissen SE
    Lorundrostat Efficacy and Safety in Uncontrolled Hypertension. Reply.
    N Engl J Med. 2025;393:726-727.
    PubMed    
    
    
    
33. POLLOCK JM 3RD
    Lorundrostat Efficacy and Safety in Uncontrolled Hypertension.
    N Engl J Med. 2025;393:726.
    PubMed    
    
    
    
34. BURGOS E, Fernandez Fernandez B, Ortiz A
    Lorundrostat Efficacy and Safety in Uncontrolled Hypertension.
    N Engl J Med. 2025;393:725-726.
    PubMed    
    
    
    June 2025
35. GARVEY WT, Bluher M, Osorto Contreras CK, Davies MJ, et al
    Coadministered Cagrilintide and Semaglutide in Adults with Overweight or Obesity.
    N Engl J Med. 2025 Jun 22. doi: 10.1056/NEJMoa2502081.
    PubMed     Abstract available
    
    
    May 2025
36. MARON BA
    Sotatercept and the Clinical Transformation of Pulmonary Arterial Hypertension.
    N Engl J Med. 2025;392:2059-2061.
    PubMed    
    
    
    April 2025
37. LAFFIN LJ, Kopjar B, Melgaard C, Wolski K, et al
    Lorundrostat Efficacy and Safety in Patients with Uncontrolled Hypertension.
    N Engl J Med. 2025 Apr 23. doi: 10.1056/NEJMoa2501440.
    PubMed     Abstract available
    
    
    March 2025
38. HUMBERT M, McLaughlin VV, Badesch DB, Ghofrani HA, et al
    Sotatercept in Patients with Pulmonary Arterial Hypertension at High Risk for Death.
    N Engl J Med. 2025 Mar 31. doi: 10.1056/NEJMoa2415160.
    PubMed     Abstract available
    
    
    
39. MAGNUSSEN C, Alegre-Diaz J, Al-Nasser LA, Amouyel P, et al
    Global Effect of Cardiovascular Risk Factors on Lifetime Estimates.
    N Engl J Med. 2025 Mar 30. doi: 10.1056/NEJMoa2415879.
    PubMed     Abstract available
    
    
    January 2025
40. VAIDYA A, Morlote M, Moussa M, Barletta J, et al
    Targeting a Hormonal Cause of Hypertension.
    N Engl J Med. 2025;392:e14.
    PubMed    
    
    
    November 2024
41. BI Y, Li M, Liu Y, Li T, et al
    Intensive Blood-Pressure Control in Patients with Type 2 Diabetes.
    N Engl J Med. 2024 Nov 16. doi: 10.1056/NEJMoa2412006.
    PubMed     Abstract available
    
    
    June 2024
42. MANRIQUE-ACEVEDO C, Hirsch IB, Eckel RH
    Prevention of Cardiovascular Disease in Type 1 Diabetes. Reply.
    N Engl J Med. 2024;390:2227.
    PubMed    
    
    
    May 2024
43. NAJEM M, Dong E
    Esophageal Varices, White-Nipple Sign, and Portal Hypertensive Gastropathy.
    N Engl J Med. 2024;390:e47.
    PubMed    
    
    
    
44. LI G, Lin Y, Yang J, Anderson CS, et al
    Intensive Ambulance-Delivered Blood-Pressure Reduction in Hyperacute Stroke.
    N Engl J Med. 2024 May 16. doi: 10.1056/NEJMoa2314741.
    PubMed     Abstract available
    
    
    
45. EDLOW JA
    Lowering Blood Pressure in Stroke Patients in the Ambulance - A Bridge Too Close?
    N Engl J Med. 2024 May 16. doi: 10.1056/NEJMe2402356.
    PubMed    
    
    
    April 2024
46. KUROLAP A, Chai Gadot C, Baris Feldman H
    Corin and Left Atrial Cardiomyopathy, Hypertension, Arrhythmia, and Fibrosis. Reply.
    N Engl J Med. 2024;390:1539-1540.
    PubMed    
    
    
    
47. ABASSI Z, Azzam ZS, Heyman SN
    Corin and Left Atrial Cardiomyopathy, Hypertension, Arrhythmia, and Fibrosis.
    N Engl J Med. 2024;390:1539.
    PubMed    
    
    
    
48. GLADYSHEVA IP, Wang D, Reed GL
    Corin and Left Atrial Cardiomyopathy, Hypertension, Arrhythmia, and Fibrosis.
    N Engl J Med. 2024;390:1538-1539.
    PubMed    
    
    
    
49. DOMINY J, Koch C, Lamarche L, Denning D, et al
    Corin and Left Atrial Cardiomyopathy, Hypertension, Arrhythmia, and Fibrosis.
    N Engl J Med. 2024;390:1537-1538.
    PubMed    
    
    
    
50. CHEN B, Wei M
    Aortic Coarctation.
    N Engl J Med. 2024;390:1420.
    PubMed    
    
    
    
51. VAZQUEZ MA, Oliver G, Amarasingham R, Sundaram V, et al
    Pragmatic Trial of Hospitalization Rate in Chronic Kidney Disease.
    N Engl J Med. 2024;390:1196-1206.
    PubMed     Abstract available
    
    
    December 2023
52. JAUREGUI R, Busis NA
    Idiopathic Intracranial Hypertension.
    N Engl J Med. 2023;389:2467.
    PubMed    
    
    
    November 2023
53. BARIS FELDMAN H, Chai Gadot C, Zahler D, Mory A, et al
    Corin and Left Atrial Cardiomyopathy, Hypertension, Arrhythmia, and Fibrosis.
    N Engl J Med. 2023;389:1685-1692.
    PubMed     Abstract available
    
    
    October 2023
54. DESAI AS, Sweetser MT, Bakris GL
    Zilebesiran for Hypertension. Reply.
    N Engl J Med. 2023;389:1439-1440.
    PubMed    
    
    
    
55. VAN TWIST DJL, Kalic H
    Zilebesiran for Hypertension.
    N Engl J Med. 2023;389:1438-1439.
    PubMed    
    
    
    
56. LIFSCHITZ M
    Zilebesiran for Hypertension.
    N Engl J Med. 2023;389:1438.
    PubMed    
    
    
    
57. ABASHEVA D, Fernandez-Fernandez B, Ortiz A
    Zilebesiran for Hypertension.
    N Engl J Med. 2023;389:1438.
    PubMed    
    
    

Thank you for your interest in scientific medicine.

AMEDEO Hypertension is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum